These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
487 related items for PubMed ID: 17409420
1. Tumors initiated by constitutive Cdk2 activation exhibit transforming growth factor beta resistance and acquire paracrine mitogenic stimulation during progression. Corsino P, Davis B, Law M, Chytil A, Forrester E, Nørgaard P, Teoh N, Law B. Cancer Res; 2007 Apr 01; 67(7):3135-44. PubMed ID: 17409420 [Abstract] [Full Text] [Related]
2. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice. van Rossum AG, van Bragt MP, Schuuring-Scholtes E, van der Ploeg JC, van Krieken JH, Kluin PM, Schuuring E. BMC Cancer; 2006 Mar 14; 6():58. PubMed ID: 16536875 [Abstract] [Full Text] [Related]
3. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties. Bearss DJ, Lee RJ, Troyer DA, Pestell RG, Windle JJ. Cancer Res; 2002 Apr 01; 62(7):2077-84. PubMed ID: 11929828 [Abstract] [Full Text] [Related]
4. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc. Nass SJ, Dickson RB. Clin Cancer Res; 1998 Jul 01; 4(7):1813-22. PubMed ID: 9676860 [Abstract] [Full Text] [Related]
6. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. Nature; 1994 Jun 23; 369(6482):669-71. PubMed ID: 8208295 [Abstract] [Full Text] [Related]
7. Cell cycle basis for the onset and progression of c-Myc-induced, TGFalpha-enhanced mouse mammary gland carcinogenesis. Liao DJ, Natarajan G, Deming SL, Jamerson MH, Johnson M, Chepko G, Dickson RB. Oncogene; 2000 Mar 02; 19(10):1307-17. PubMed ID: 10713672 [Abstract] [Full Text] [Related]
15. The SV40 small t-antigen prevents mammary gland differentiation and induces breast cancer formation in transgenic mice; truncated large T-antigen molecules harboring the intact p53 and pRb binding region do not have this effect. Goetz F, Tzeng YJ, Guhl E, Merker J, Graessmann M, Graessmann A. Oncogene; 2001 Apr 26; 20(18):2325-32. PubMed ID: 11402328 [Abstract] [Full Text] [Related]
16. WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis. Li M, Lewis B, Capuco AV, Laucirica R, Furth PA. Oncogene; 2000 Feb 21; 19(8):1010-9. PubMed ID: 10713684 [Abstract] [Full Text] [Related]
17. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution. Shin DH, Jang SH, Kang BC, Kim HJ, Oh SH, Kong G. J Cell Physiol; 2011 May 21; 226(5):1340-52. PubMed ID: 20945346 [Abstract] [Full Text] [Related]
18. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice. Strizzi L, Bianco C, Normanno N, Seno M, Wechselberger C, Wallace-Jones B, Khan NI, Hirota M, Sun Y, Sanicola M, Salomon DS. J Cell Physiol; 2004 Nov 21; 201(2):266-76. PubMed ID: 15334661 [Abstract] [Full Text] [Related]
19. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis. Blavier L, Lazaryev A, Dorey F, Shackleford GM, DeClerck YA. Cancer Res; 2006 Mar 01; 66(5):2691-9. PubMed ID: 16510589 [Abstract] [Full Text] [Related]
20. MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia. Daphna-Iken D, Shankar DB, Lawshé A, Ornitz DM, Shackleford GM, MacArthur CA. Oncogene; 1998 Nov 26; 17(21):2711-7. PubMed ID: 9840935 [Abstract] [Full Text] [Related] Page: [Next] [New Search]